Expertise in
12
conditions

Anders Perner

Copenhagen, DK 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
12
conditions
Copenhagen, DK 
OverviewLocationsClinical Research

Overview

Anders Perner practices in Copenhagen, Denmark. Mr. Perner is highly rated in 12 conditions, according to our data. His top areas of expertise are Sepsis, Peptic Ulcer, Gastrointestinal Bleeding, and Cerebral Hypoxia.

His clinical research consists of co-authoring 505 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Copenhagen, Denmark
Other Locations
Sygehus Lillebaelt
Kolding, Denmark
Odense, Denmark
Herning, Denmark
Slagelse, Denmark
Hillerod, Denmark
Kobenhavn O, 2100, Denmark

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Goal Directed Fluid Removal With Furosemide in Intensive Care Patients With Fluid Overload - A Randomised, Blinded, Placebo-controlled Trial (GODIF).
Goal Directed Fluid Removal With Furosemide in Intensive Care Patients With Fluid Overload - A Randomised, Blinded, Placebo-controlled Trial (GODIF).
Enrollment Status: Recruiting
Publish Date: February 06, 2025
Intervention Type: Drug
Study Phase: Phase 4
Efficacy and Safety of 72-hour Infusion of Prostacyclin (1 Nanogram(ng)/ Kilo(kg)/Minute(Min)) in Patients With COVID-19 Induced Pulmonary Endotheliopathy
Efficacy and Safety of 72-hour Infusion of Prostacyclin (1 Nanogram(ng)/ Kilo(kg)/Minute(Min)) in Patients With COVID-19 Induced Pulmonary Endotheliopathy
Enrollment Status: Completed
Publish Date: May 07, 2024
Intervention Type: Drug
Study Drug: Iloprost
Study Phase: Phase 2
Efficacy and Safety of 72-hour Infusion of Prostacyclin (1 Nanogram(ng)/Kilo(kg)/Minute(Min)) in Patients With Septic Shock Induced Endotheliopathy - a Multicentre Randomized, Placebo-controlled, Blinded, Investigator-initiated Trial
Efficacy and Safety of 72-hour Infusion of Prostacyclin (1 Nanogram(ng)/Kilo(kg)/Minute(Min)) in Patients With Septic Shock Induced Endotheliopathy - a Multicentre Randomized, Placebo-controlled, Blinded, Investigator-initiated Trial
Enrollment Status: Completed
Publish Date: May 07, 2024
Intervention Type: Drug
Study Drug: Iloprost
Study Phase: Phase 2/Phase 3
Does ROCKING Chairs Calm Delirious Patients in the Intensive Care Unit: a Multicenter Clinical Randomized Trial (RockingICU)
Does ROCKING Chairs Calm Delirious Patients in the Intensive Care Unit: a Multicenter Clinical Randomized Trial (RockingICU)
Enrollment Status: Completed
Publish Date: March 19, 2024
Intervention Type: Device
Study Phase: Not Applicable
Improving Outcome of Necrotizing Fasciitis: Elucidation of Complex Host and Pathogen Signatures That Dictate Severity of Tissue Infection
Improving Outcome of Necrotizing Fasciitis: Elucidation of Complex Host and Pathogen Signatures That Dictate Severity of Tissue Infection
Enrollment Status: Completed
Publish Date: April 23, 2018
A Randomised Blinded Placebo Controlled Trial of Hydrocortisone in Critically Ill Patients With Septic Shock
A Randomised Blinded Placebo Controlled Trial of Hydrocortisone in Critically Ill Patients With Septic Shock
Enrollment Status: Completed
Publish Date: December 12, 2017
Intervention Type: Drug
Study Phase: Phase 4
View 5 Less Clinical Trials

505 Total Publications

Targeted Tissue Perfusion Versus Macrocirculatory-Guided Standard Care in Patients With Septic Shock: A Randomized Clinical Trial-The TARTARE-2S Trial.
Targeted Tissue Perfusion Versus Macrocirculatory-Guided Standard Care in Patients With Septic Shock: A Randomized Clinical Trial-The TARTARE-2S Trial.
Journal: Critical care medicine
Published: October 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Perner's expertise for a condition
ConditionClose
View All 20 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile